ASH 2014: Phase Ib dose escalation trial of SAR650984 (anti-CD38 monoclonal antibody) in combination with lenalidomide and dexamethasone improves overall response rate and clinical benefi...

ASH 2014: Phase Ib dose escalation trial of SAR650984 (anti-CD38 monoclonal antibody) in combination with lenalidomide and dexamethasone improves overall response rate and clinical benefi...

EMJ

4 years
1,145 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Thomas Martin (University of California San Francisco, San Francisco, CA) discusses a phase Ib dose escalation trial of SAR650984 (anti-CD38 monoclonal antibody) in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma.
Up Next Autoplay
Trends in Breast Cancer Death Rates
Trends in Breast Cancer Death Rates
Category: Breast Cancer
0 Views
Cancer-News 21 minutes
Breast Cancer Trends in U.S.
Breast Cancer Trends in U.S.
Category: Breast Cancer
0 Views
Cancer-News 25 minutes
What Happens When You Have An ATRX Deletion?
What Happens When You Have An ATRX Deletion?
Category: Kidney Cancer
0 Views
Mount Sinai Health System 32 minutes
Neuroblastoma in Older Children May Respond to Tazemetostat
Neuroblastoma in Older Children May Respond to Tazemetostat
Category: Kidney Cancer
1 Views
Mount Sinai Health System 1 hour
Lower Costs in Breast Cancer: How This Affects Treatment
Lower Costs in Breast Cancer: How This Affects Treatment
Category: Breast Cancer
0 Views
ONeal Comprehensive Cancer Center 1 hour
When Can This Be Used In Clinical Practice?
When Can This Be Used In Clinical Practice?
Category: Other
2 Views
Baylor College of Medicine 2 days
New Testing for Thyroid Cancer
New Testing for Thyroid Cancer
Category: Other
4 Views
Baylor College of Medicine 2 days
Lower Costs for Patients in Metastatic Breast Cancer
Lower Costs for Patients in Metastatic Breast Cancer
Category: Breast Cancer
15 Views
ONeal Comprehensive Cancer Center 4 days
New Technology to Streamline Drug Discovery
New Technology to Streamline Drug Discovery
Category: Other
5 Views
Cancer-News 5 days
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
15 Views
Cancer-News 5 days